Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl…
Source: Yahoo Finance
Sector & Industry
Corbus Pharmaceuticals Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Corbus Pharmaceuticals Holdings, Inc. at a Glance
| Company | Corbus Pharmaceuticals Holdings, Inc. |
| Ticker | CRBP |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $11.08 |
| Market cap | $214.30M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$6.11 |
| 52-week high | $20.56 |
| 52-week low | $7.12 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 2.64 |
| Return on equity (ROE) | -95.58% |
| Debt-to-equity | 4.17% |
| Average volume | 429,263 |
| Shares outstanding | 19.34M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 36 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Corbus Pharmaceuticals Holdings, Inc.'s current P/E ratio?
- Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Corbus Pharmaceuticals Holdings, Inc.'s market capitalisation?
- Corbus Pharmaceuticals Holdings, Inc.'s market cap is $214.30M based on our latest snapshot. See how it ranks by market cap →
- What is CRBP's 52-week range?
- Over the past 52 weeks, CRBP has traded between $7.12 and $20.56. What does the 52-week range mean? →
- How volatile is Corbus Pharmaceuticals Holdings, Inc. compared to the market?
- Corbus Pharmaceuticals Holdings, Inc. has a beta of 2.64, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Corbus Pharmaceuticals Holdings, Inc. pay a dividend?
- Corbus Pharmaceuticals Holdings, Inc. does not currently pay a dividend according to our latest data.
- What exchange is CRBP listed on?
- CRBP is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Corbus Pharmaceuticals Holdings, Inc. in?
- Corbus Pharmaceuticals Holdings, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →